Outcome of Dental Implant Therapy in Patients Treated With Antiresorptive Medication

Who May Qualify: - Patient with cancer or osteoporosis, treated with antiresorptive treatment. - The patients should have sufficient compliance, this includes willingness to have the planned assessments - The patient should have an expected life span at enrollment of at least 2 years. - The local bone quality and quantity should be sufficient for implant insertion without bone augmentation and is classified according to the classification by Cawood \& Howell 1988. Who Should NOT Join This Trial: - \> 10 cigarettes daily - HbA1c \> 53 mmol/mol - Poor oral hygiene - Poor general condition: ECOG score 3 or 4. - Poor prognosis: Expected survival \<2 year is an exclusion cause. - Presence of metastases of the liver brain. - Poor local jaw bone quality acc. to Cawood classification stage 3 or 4. - Unwillingness to comply with the planned assessments and recordings Always talk to your doctor about whether this trial is right for you.